glp 1 class of drugs Lesson: Oral Semaglutide: A New GLP-1 Receptor Agonist Product for the Treatment Type 2 Diabetes Chart: 1 in 8 Americans
Description
2019;370:111932 Jia XT, Ye-Tian, Yuan-Li, Zhang GJ, Liu ZQ, Di ZL, et al
For patients, this means navigating a more complex treatment landscape, where outcomes depend not only on the drug itself but on the system surrounding it
Four more gliptins, namely teneligliptin, anagliptin, omarigliptin, and trelagliptin are only approved in the Japanese and Korean markets
Diabetes Care (2014) 37(10):272330
Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL
doi: 10.1186/s12933-021-01412-5
